Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment

被引：2
|
作者：
Serrati, Simona [1 ]
Margheri, Francesca [2 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Lab Expt Pharmacol, I-70124 Bari, Italy
[2] Univ Florence, Dept Expt & Clin Biomed Sci, I-50134 Florence, Italy
来源：
BIOMOLECULES | 2023年 / 13卷 / 08期
关键词：
IMMUNE; RESISTANCE;
D O I：
10.3390/biom13081209
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Iosune Baraibar
    Ignacio Melero
    Mariano Ponz-Sarvise
    Eduardo Castanon
    Drug Safety, 2019, 42 : 281 - 294
  • [2] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
    Baraibar, Iosune
    Melero, Ignacio
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    DRUG SAFETY, 2019, 42 (02) : 281 - 294
  • [4] Current landscape of biomarker development for immune checkpoint inhibitors targeting PD-1/PD-L1 pathway in oncology
    Chaput, Lisa
    Jordheim, Lars Petter
    THERAPIE, 2021, 76 (06): : 597 - 615
  • [5] Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives
    Ran, Xiongwen
    Yang, Kai
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2007 - 2014
  • [6] Bibliometric analysis of the research landscape of PD-1/PD-L1 inhibitors in the treatment of bowel cancer
    Luo, Qingwei
    Zhao, Yang
    Li, Zhihong
    ASIAN JOURNAL OF SURGERY, 2025, 48 (02) : 1305 - 1307
  • [7] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [8] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
    Sadal Refae
    Jocelyn Gal
    Nathalie Ebran
    Josiane Otto
    Delphine Borchiellini
    Frederic Peyrade
    Emmanuel Chamorey
    Patrick Brest
    Gérard Milano
    Esma Saada-Bouzid
    Investigational New Drugs, 2020, 38 : 160 - 171
  • [10] Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas
    Ribatti, Domenico
    Cazzato, Gerardo
    Tamma, Roberto
    Annese, Tiziana
    Ingravallo, Giuseppe
    Specchia, Giorgina
    FRONTIERS IN ONCOLOGY, 2024, 14
12345